share_log

NeuroSense Therapeutics Q4 EPS $(0.16) Beats $(0.23) Estimate

Moomoo 24/7 ·  Apr 5 16:49

NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 40.74 percent increase over losses of $(0.27) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment